Abstract
Rationale
Protein degraders are small molecules that promote cellular degradation of a target protein. Degraders simultaneously bind to their target and an E3 ligase, bringing them into close spatial proximity, but the formation of this ternary complex is difficult to measure with many biophysical techniques.
Methods
Native mass spectrometry (nMS) is an effective label‐free technique to identify the complexes formed by proteolysis‐targeting chimeras (PROTACs). It can monitor the formation of ternary E3–PROTAC–target complexes and detect intermediate binary species. Experiments are described using a Synapt G2Si (Waters) equipped with a nano‐electrospray ionisation source.
Results
The protocol describes nMS experiments for measuring the complexes formed by PROTAC molecules. It also describes how to investigate differences in the affinity of PROTAC complexes, whether a PROTAC shows specificity for a given target and whether a PROTAC shows cooperative behaviour.
Conclusions
Here, we provide step‐by‐step instructions for the sample preparation of PROTAC complexes and their nMS interrogation to obtain optimal information on their binding modes.
1. INTRODUCTION
Proteolysis‐targeting chimeras (PROTACs) are small‐molecule degraders that eliminate target proteins by programming them for degradation by the cell. 1 , 2 PROTACs are bifunctional molecules that consist of two ligands joined by a linker region. 3 The ligands are specific for a target protein and an E3 ligase respectively. 4 The PROTAC therefore brings the two proteins into close spatial proximity, causing the E3 ligase to catalyse ubiquitination of the target protein, thereby labelling it for proteasomal degradation by the cell. 5 The term ‘target protein’, which is also referred to as the ‘substrate’ or ‘protein of interest’, will be used throughout the text.
A main challenge in studying PROTACs is the ternary binding system that involves the E3 ligase, the target protein and the PROTAC. Many biochemical methods have been developed to measure binary systems, often requiring adaptations and approximations to study ternary complexes. Such methods include surface plasmon resonance, isothermal titration calorimetry and size exclusion chromatography. 6 , 7 , 8 Native mass spectrometry (nMS) is a highly applicable method to study protein complexes formed by PROTACs as it reports on multiple binding stoichiometries present in dynamic protein mixtures, including species populated to a low extent. This sensitive, label‐free method can be applied to proteins of varying mass and polydispersity, i.e. different shapes and sizes. Protocols detailing nMS experiments are available that describe analysis of large protein complexes, 9 analysis of monoclonal antibodies 10 and direct characterisation of overproduced proteins, 11 among others. We have recently demonstrated that nMS can report on the formation of ternary complexes, determine the binding specificity of a PROTAC and compare complex formation with multiple target proteins in a single measurement. 12
Whilst this protocol was developed for PROTACs, it is suitable for the analysis of other protein degraders such as molecular glues 13 , 14 (as demonstrated by Bellamy‐Carter et al 15 ), SNIPERS 16 and other bifunctional molecules. 17
1.1. Materials
Analytical balance (Fisher Scientific catalogue no. 15907500)
Fisherbrand™ accuSpin™ Micro 17 microcentrifuge (Fisher Scientific catalogue no. 13‐100‐675)
Graduated cylinders, 10–500 mL
Microcentrifuge tubes 1.5 mL (Fisher Scientific catalogue no. 05‐408‐129)
Desalting columns, Bio‐Spin® P‐6 gel columns, Tris buffer (BIO‐RAD catalogue no.7326227)
96‐well microdialysis plate, 3.5 MWCO (Thermo Scientific catalogue no. 88262)
Metal spatula
Deionised water (Fisher Scientific catalogue no. 23‐751610)
Pipettes (Fisher Scientific catalogue no. 14‐388‐100)
Pipette tips, variable from 0.1 to 1000 μL
Gel loader tip (Eppendorf catalogue no. 0030001222)
Mass spectrometer for native protein studies (examples of commercially available instruments and their corresponding recommended settings are described in Section 2.7)
Nano‐electrospray emitters. We recommend using metal‐coated borosilicate capillaries (Thermo Scientific part number ES380).
UV–visible spectrophotometer (optional; see Section 2.1.3) (Varian Cary 50 UV–Vis spectrophotometer)
UV–visible cuvettes (optional; see Section 2.1.3) (Fisher Scientific catalogue no. 14‐955‐127)
Nanodrop (optional; see Section 2.1.3) (Thermo Scientific NanoDrop 1000)
Dry wipes (Fisher Scientific catalogue no. 06‐666A)
1.2. Chemicals
Ammonium acetate (Thermo Scientific catalogue no. A16343.30)
Dimethylsulfoxide (DMSO) LC/MS grade (Thermo Scientific catalogue no. 85190)
PROTACs
Purified E3 ligase
Purified target proteins
Bovine serum albumin (BSA) (optional; see Section 2.1.3) (Sigma‐Aldrich catalogue no. A2153)
Myoglobin (Sigma‐Aldrich catalogue no. M0630)
Leu‐enkephalin (Leu‐Enk) acetate salt from Bachem (Fischer Scientific catalogue no. 50‐259‐648)
Bradford reagent (optional; see Section 2.1.3) (Thermo Scientific catalogue no. 23238)
2. METHOD
2.1. Buffer exchange proteins into ammonium acetate/dissolve PROTAC in DMSO
Ammonium acetate is normally the solution of choice for nMS experiments, as it is highly volatile and hence evaporates from the proteins readily during desolvation. As the PROTAC will likely be dissolved in DMSO or another organic solvent, ensure that the proteins can be analysed in the presence of this and be aware of any alterations that it confers to the protein signal (i.e. charge reduction in the presence of DMSO 18 , 19 ). Moreover, keep the final DMSO/organic solvent concentration as low as possible; in this protocol the DMSO concentration is kept at 1% and it is not recommended to exceed 5%.
2.1.1. Prepare ammonium acetate solution (200 mM, 50 mL); 15–30 min
| Time | Step | Comments/tips |
|---|---|---|
| 15–30 min |
|
|
2.1.2. Buffer exchange proteins into ammonium acetate
| Time | Step | Comments/tips |
|---|---|---|
| Micro bio spin chromatography columns | ||
| 15–30 min |
|
|
If there is a severe loss of protein concentration when using the spin columns, or if the protein target is intrinsically disordered and/or prone to aggregation, then microdialysis devices can be used as an alternative.
| Time | Step | Comments/tips |
|---|---|---|
| Microdialysis | ||
| 2 h |
|
|
2.1.3. Measuring protein concentration with Bradford assay or nanodrop
Bradford assay
| Time | Step | Comments/tips | ||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 45–60 min |
|
|
Nanodrop
| Time | Step | Comments/tips |
|---|---|---|
| 15–30 min |
|
|
2.1.4. Prepare PROTAC solution
| Time | Step | Comments/tips |
|---|---|---|
| 15–30 min |
|
|
2.2. Protein quality control and determination of optimum protein concentrations
This step is to measure the mass of the individual proteins and assess their purity.
2.2.1. Analyse the proteins individually for quality control, to optimise concentrations and to measure their mass
| Time | Step | Comments/tips |
|---|---|---|
| 45–60 min per sample |
|
|
2.3. Test for ternary and binary complex formation
This step is to identify whether ternary complexes are formed with a given E3–PROTAC–target combination. Identification of which charge states the complex is present in (see Data S1) will also help with data analysis at further points in the protocol (e.g. Section 2.6). In these spectra, the presence of binary interactions (PROTAC–E3 and PROTAC–target) in the reaction mixture can also be identified. Figure 1A shows an example mass spectrum of a target and E3 in the absence of PROTAC, where no interaction occurs. Here, the target protein, highlighted in blue, is present in charge states 6+ to 19+, with most of the intensity in the 6+ and 7+ charge states. The E3 ligase, highlighted in green, is present in charge states 9+ to 12+. Figure 1B shows a spectrum of the same target and E3 as in Figure 1A, with the addition of 10 μM PROTAC. In this case, the ternary complex (highlighted in pink) and target–PROTAC and E3–PROTAC binary complexes are observed.
FIGURE 1.

Characterising the binding equilibrium between the E3 ligase (5 μM), the proteolysis‐targeting chimera (PROTAC) and the target (5 μM) by nMS in the absence of PROTAC (A) and in the presence of PROTAC (10 μM) (B). Figure adapted from Beveridge et al. 12 [Color figure can be viewed at wileyonlinelibrary.com]
| Time | Step | Comments/tips |
|---|---|---|
| 15–30 min |
|
|
2.4. Test for specificity
PROTACs can recruit closely related target proteins to different extents, 7 and the specificity of a PROTAC can be estimated by nMS by comparing the relative intensity of the ternary complex to that of the unbound E3 ligase (Figure 2A).
| Time | Step | Comments/tips |
|---|---|---|
| 15–30 min |
|
|
FIGURE 2.

nMS for specificity (A), cooperativity (B) and competition assay studies (C). [Color figure can be viewed at wileyonlinelibrary.com]
2.5. Test cooperativity
In a cooperative system, the ternary complex will form more readily than either of the binary complexes, which is thought to contribute to the specificity of the PROTAC. Cooperativity can be measured by comparing binary complex formation to ternary complex formation. In a cooperative system, binary complexes between the PROTAC and either protein will be low (Figure 2B).
| Time | Step | Comments/tips |
|---|---|---|
| 15–30 min |
|
|
2.6. Develop competition assays
To take full advantage of the ability of nMS to measure complex reaction mixtures, assays can be developed in which the specificity for multiple target proteins can be measured in a single experiment. Measuring the target proteins in mixtures is more time‐effective than separate measurements and has the added advantage of providing information on competition between targets forming the ternary complexes (Figure 2C).
| Time | Step | Comments/tips |
|---|---|---|
| 15–30 min |
|
|
2.7. Example instrument settings
The following tables provide published non‐default/tuneable settings for nMS studies on ternary complexes. Adjustable parameters are both sample and instrument specific which can be tuned to produce optimum results. We suggest these settings as a starting point for experiments.
2.7.1. Example source parameters for Synapt G2Si (Waters), taken from Beveridge et al 12
| Capillary voltage | 1.1–1.3 kV |
| Sample cone | 40–80 V |
| Source offset | 30–100 V |
| Ion mobility spectrometry (IMS) bias voltage | 2 V |
| Source temperature | 40°C |
| Trap gas flow | 2–3 mL/min |
2.7.2. Example instrument parameters for Q‐exactive HF (Thermo Fisher Scientific) with Triversa NanoMate (Advion) taken from Bellamy‐Carter et al 15
| Ionisation voltage | 1.75 kV |
| Gas pressure | 0.3 psi |
| Source temperature | 250°C |
| In‐source dissociation | Off |
| S‐lens radiofrequency (RF) | 100 |
| Maximum ion injection time | 100 ms |
| Automatic gain control | 1 × 106 |
| Resolution | 15 000 |
3. QUALITY CONTROL
To ensure good working condition of the mass spectrometer, standards are infused and the intensity is monitored. For example, Leu‐Enk (1 ng/μL in 50:50 (v/v) acetonitrile–water + 0.1% formic acid) should give signal intensity of >1e7, myoglobin (5 μM in 100 mM ammonium acetate) should give signal intensity of >1e5 and BSA (5 μM in 100 mM ammonium acetate) should give signal intensity of >1e4 using our Waters Synapt G2Si (Figures S1–S3).
PEER REVIEW
The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1002/rcm.9604.
Supporting information
Data S1. Supporting information.
Figure S1. nESI‐MS of Leu‐Enk (1 ng/ul) in 50:50 acetonitrile/water + 0.1% Formic Acid.
Figure S2. nESI‐MS of Myoglobin (5 μM) in ammonium acetate (100 mM).
Figure S3. nESI‐MS of BSA (5 μM) in ammonium acetate (100 mM), charge states [M+21H]21+ to [M+23H]23+ correspond to a dimer.
ACKNOWLEDGEMENTS
R.B. acknowledges support of a UKRI Future Leaders Fellowship (grant reference MR/T020970/1) and a Chancellor's Fellowship from the University of Strathclyde (2020‐2022).
Ahmed IMM, Beveridge R. Native mass spectrometry interrogation of complexes formed during targeted protein degradation. Rapid Commun Mass Spectrom. 2023;37(22):e9604. doi: 10.1002/rcm.9604
DATA AVAILABILITY STATEMENT
Data sharing not applicable ‐ no new data generated.
REFERENCES
- 1. Collins I, Wang H, Caldwell JJ, Chopra R. Chemical approaches to targeted protein degradation through modulation of the ubiquitin–proteasome pathway. Biochem J. 2017;474(7):1127‐1147. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Paiva S‐L, Crews CM. Targeted protein degradation: Elements of PROTAC design. Curr Opin Chem Biol. 2019;50:111‐119. doi: 10.1016/j.cbpa.2019.02.022 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Bondeson DP, Mares A, Smith IED, et al. Catalytic in vivo protein knockdown by small‐molecule PROTACs. Nat Chem Biol. 2015;11(8):611‐617. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Flanagan JJ, Neklesa TK. Targeting nuclear receptors with PROTAC degraders. Mol Cell Endocrinol. 2019;493:110452. [DOI] [PubMed] [Google Scholar]
- 5. Zengerle M, Chan K‐H, Ciulli A. Selective small molecule induced degradation of the BET bromodomain protein BRD4. ACS Chem Biol. 2015;10(8):1770‐1777. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Roy MJ, Winkler S, Hughes SJ, et al. SPR‐measured dissociation kinetics of PROTAC ternary complexes influence target degradation rate. ACS Chem Biol. 2019;14(3):361‐368. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Gadd MS, Testa A, Lucas X, et al. Structural basis of PROTAC cooperative recognition for selective protein degradation. Nat Chem Biol. 2017;13(5):514‐521. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Maniaci C, Hughes SJ, Testa A, et al. Homo‐PROTACs: Bivalent small‐molecule dimerizers of the VHL E3 ubiquitin ligase to induce self‐degradation. Nat Commun. 2017;8(1):830. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Kirshenbaum N, Michaelevski I, Sharon M. Analyzing large protein complexes by structural mass spectrometry. J Vis Exp. 2010;40:e1954. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Rosati S, Yang Y, Barendregt A, Heck AJR. Detailed mass analysis of structural heterogeneity in monoclonal antibodies using native mass spectrometry. Nat Protoc. 2014;9(4):967‐976. [DOI] [PubMed] [Google Scholar]
- 11. Vimer S, Ben‐Nissan G, Sharon M. Direct characterization of overproduced proteins by native mass spectrometry. Nat Protoc. 2020;15(2):236‐265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Beveridge R, Kessler D, Rumpel K, Ettmayer P, Meinhart A, Clausen T. Native mass spectrometry can effectively predict PROTAC efficacy. ACS Central Sci. 2020;6(7):1223‐1230. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Mayor‐Ruiz C, Bauer S, Brand M, et al. Rational discovery of molecular glue degraders via scalable chemical profiling. Nat Chem Biol. 2020;16(11):1199‐1207. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Jackson C, Beveridge R. Native mass spectrometry of complexes formed by molecular glues revealed stoichiometric rearrangement of E3 ligases. bioRxiv. 2023. doi: 10.1101/2023.02.03.526954 [DOI] [PubMed] [Google Scholar]
- 15. Bellamy‐Carter J, Mohata M, Falcicchio M, et al. Discovering protein–protein interaction stabilisers by native mass spectrometry. Chem Sci. 2021;12(32):10724‐10731. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Naito M, Ohoka N, Shibata N. SNIPERs – Hijacking IAP activity to induce protein degradation. Drug Discov Today Technol. 2019;31:35‐42. [DOI] [PubMed] [Google Scholar]
- 17. Chen P‐H, Hu Z, An E, et al. Modulation of phosphoprotein activity by phosphorylation targeting chimeras (PhosTACs). ACS Chem Biol. 2021;16(12):2808‐2815. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Chan DS‐H, Matak‐Vinković D, Coyne AG, Abell C. Insight into protein conformation and subcharging by DMSO from native ion mobility mass spectrometry. ChemistrySelect. 2016;1(18):5686‐5690. [Google Scholar]
- 19. Tjernberg A, Markova N, Griffiths WJ, Hallén D. DMSO‐related effects in protein characterization. J Biomol Screen. 2006;11(2):131‐137. [DOI] [PubMed] [Google Scholar]
- 20. Migas LG, France AP, Bellina B, Barran PE. ORIGAMI: A software suite for activated ion mobility mass spectrometry (aIM‐MS) applied to multimeric protein assemblies. Int J Mass Spectrom. 2018;427:20‐28. [Google Scholar]
- 21. Marty MT, Baldwin AJ, Marklund EG, Hochberg GKA, Benesch JLP, Robinson CV. Bayesian deconvolution of mass and ion mobility spectra: from binary interactions to polydisperse ensembles. Anal Chem. 2015;87(8):4370‐4376. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Tang K, Page JS, Smith RD. Charge competition and the linear dynamic range of detection in electrospray ionization mass spectrometry. J Am Soc Mass Spectrom. 2004;15(10):1416‐1423. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data S1. Supporting information.
Figure S1. nESI‐MS of Leu‐Enk (1 ng/ul) in 50:50 acetonitrile/water + 0.1% Formic Acid.
Figure S2. nESI‐MS of Myoglobin (5 μM) in ammonium acetate (100 mM).
Figure S3. nESI‐MS of BSA (5 μM) in ammonium acetate (100 mM), charge states [M+21H]21+ to [M+23H]23+ correspond to a dimer.
Data Availability Statement
Data sharing not applicable ‐ no new data generated.
